Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bladder wall calcification after topical mitomycin C.

A J Alter1, G H Malek

  • 1Department of Radiology, Jackson Clinic, Madison, Wisconsin.

The Journal of Urology
|November 1, 1987
PubMed
Summary
This summary is machine-generated.

Bladder calcification can occur after intravesical mitomycin C treatment for transitional cell carcinoma. This case highlights a potential side effect of this common bladder cancer therapy.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Microcontrolled pyro-electric instrument for measuring X-ray intensity in mammography.

Medical & biological engineering & computing·2006
Same author

Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study.

The Journal of urology·1999
Same author

Single-dose oral ciprofloxacin compared with cefotaxime and placebo for prophylaxis during transurethral surgery.

The Journal of antimicrobial chemotherapy·1999
Same author

Efficacy of finasteride is maintained in patients with benign prostatic hyperplasia treated for 5 years. The North American Finasteride Study Group.

Urology·1999
Same author

Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group.

Urology·1999
Same author

Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy.

Urology·1998
Same journal

On the Memoryless Property in Markov Models for NMIBC Cost-Effectiveness Analysis.

The Journal of urology·2026
Same journal

Multi-institutional Assessment of Performance Metrics for MRI-targeted Transperineal Prostate Biopsy.

The Journal of urology·2026
Same journal

Urinary Supersaturation in a Randomized Trial among Individuals with Recurrent Nephrolithiasis comparing Empiric versus Selective Preventive Therapy: The URINE Trial.

The Journal of urology·2026
Same journal

The FDA Should Allow More BCG Strains into the US Market: How Recent Landmark Trials Expose a Regulatory Paradox.

The Journal of urology·2026
Same journal

Let's Shift the Focus from Death to Life after Fournier's Gangrene.

The Journal of urology·2026
Same journal

Endourology and Nephrolithiasis.

The Journal of urology·2026
See all related articles

Area of Science:

  • Uro-oncology
  • Medical research
  • Clinical case study

Background:

  • Transitional cell carcinoma is a common form of bladder cancer.
  • Intravesical mitomycin C is a standard treatment for non-muscle invasive bladder cancer.
  • Treatment-related side effects require careful monitoring and documentation.